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 To the Editor 
This is in reference to the excellent manuscript by Beiser et al titled “Needs Assessment of HCV- 
Infected Individuals Experiencing Homelessness and Implications” 1 .  
The study is perhaps one of the very few to address, from a qualitative aspect, the challenging issue 
of HCV in homeless populations. The authors quite rightly state that the uptake and treatment of 
HCV in marginalised populations remain exceptionally low despite the introduction of integrated 
models in primary care. Not surprisingly, this issue has been highlighted as one of the major hurdles 
in the global strategy towards elimination of HCV. 2 
 It is interesting that more than two thirds (72.9%) of the homeless population included in this study 
felt that they were both interested in HCV treatment and confident they would complete the 
treatment course. More importantly, around half of those interested in treatment (53.6%) felt that a 
prompt from their community provider was a significant motivating factor. Our earlier work in 
Brighton (UK) supports this finding and suggest that that only about 5% of vulnerable adults with 
HCV engage with hospitals; thus, confirming the need for closer relationship with medical providers 
in the community to encourage HCV treatment in this cohort. 3  
Recognising these important observations, in 2015, we set up a dedicated homeless hostel based 
liver clinic for the vulnerable and homeless people in Brighton, UK. The Vulnerable Adults Liver 
Disease (VALID) study (three yr project) offers homeless people in the region a “one stop HCV clinic” 
that includes point of care testing, liver fibrosis assessment (fibroscan), alcohol and substance 
misuse counselling/social support (provided by primary care physician) and antiviral treatment. The 
clinics are run by a specialist registrar under the supervision of a Hepatologist. We have observed a 
42% prevalence of a positive HCV serology with 27% having clinically significant hepatic fibrosis. In 
contrast to a common perception that this group do not engage with health services, uptake of the 
service has been excellent (90/91, 99%). 4  Nine have commenced community-based HCV treatment 
with DAAs, and to date 6 (67%), have achieved sustained virological response. Four more are being 
worked up for HCV therapy. Compliance with treatment thus far has been 89%.  
We attribute the success of the service to its integrated and multidisciplinary nature as well as the 
role played by the hostel manager thus ensuring a personalised approach for e.g. hostels often 
acting as a collection point for direct acting antivirals (DAAs).  
This hostel based model is easy to replicate and should be widely considered to address the problem 
of low uptake of HCV in socially marginalised populations. 
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